Aduro BioTech (Series D)
Funding Details
- Awarder
- Inbox
- Date Award
- January 09, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $51,400,000
Company Info
- Company Description
- Aduro BioTech, Inc. has three interconnected and complementary vaccine platforms that provide breadth and depth in developing vaccines for cancer, infectious diseases and biodefense. The company's lead program is a randomized, controlled Phase 2 clinical trial of the sequential administration of Listeria-based CRS-207 and GVAX Pancreas in patients with metastatic pancreatic cancer.
- Market
- Cancer and infectious diseases
- Location
- Berkeley, California, USA
- Coinvestors
- Clough Capital Partners, Foresite Capital, Janus Capital, Jennison Associates, Morningside Group, OrbiMed Advisors